blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2480548

EP2480548 - INDOLIZINE INHIBITORS OF 5-LIPOXYGENASE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.01.2014
Database last updated on 14.11.2024
Most recent event   Tooltip10.01.2014Application deemed to be withdrawnpublished on 12.02.2014  [2014/07]
Applicant(s)For all designated states
Panmira Pharmaceuticals, LLC
9535 Waples Street, Suite 100
San Diego, CA 92121 / US
[2012/31]
Inventor(s)01 / ROPPE, Jeffrey, Roger
32182 Camino Guarda
Temecula CA 92592 / US
02 / PARR, Timothy
8503 Lemon Avenue
La Mesa CA 91941 / US
03 / STEARNS, Brian, Andrew
157 Beechtree Drive
Encinitas CA 92024 / US
 [2012/31]
Representative(s)Cole, William Gwyn, et al
Avidity IP
Broers Building
Hauser Forum
21 J J Thomson Avenue
Cambridge CB3 0FA / GB
[N/P]
Former [2012/31]Cole, William Gwyn, et al
avidity IP
Merlin House
Falconry Court
Baker's Lane
GB-Epping, Essex CM16 5DQ / GB
Application number, filing date10819445.723.09.2010
WO2010US49967
Priority number, dateUS20090245206P23.09.2009         Original published format: US 245206 P
[2012/31]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2011038097
Date:31.03.2011
Language:EN
[2011/13]
Type: A2 Application without search report 
No.:EP2480548
Date:01.08.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 31.03.2011 takes the place of the publication of the European patent application.
[2012/31]
Search report(s)International search report - published on:KR24.11.2011
(Supplementary) European search report - dispatched on:EP22.01.2013
ClassificationIPC:C07D471/04, C07D403/06, C07D413/12, C07D417/12, A61K31/437, A61P29/00, A61P11/00, A61P9/00
[2013/08]
CPC:
C07D471/04 (EP,US); A61P1/00 (EP); A61P11/00 (EP);
A61P11/02 (EP); A61P11/06 (EP); A61P19/02 (EP);
A61P25/04 (EP); A61P29/00 (EP); A61P3/00 (EP);
A61P35/00 (EP); A61P43/00 (EP); A61P9/00 (EP);
A61P9/10 (EP) (-)
Former IPC [2012/31]C07D471/04, C07D403/06, C07D413/12, C07D401/14, A61K31/437, A61P29/00, A61P11/00, A61P9/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/31]
Extension statesBA30.03.2012
ME30.03.2012
RS30.03.2012
TitleGerman:INDOLIZINHEMMER AUS 5-LIPOXYGENASE[2012/31]
English:INDOLIZINE INHIBITORS OF 5-LIPOXYGENASE[2012/31]
French:INHIBITEURS DE 5-LIPOXYGÉNASE À BASE D'INDOLIZINE[2012/31]
Entry into regional phase30.03.2012National basic fee paid 
30.03.2012Search fee paid 
30.03.2012Designation fee(s) paid 
30.03.2012Examination fee paid 
Examination proceduredeletedCommunication of intention to grant the patent
30.03.2012Examination requested  [2012/31]
25.10.2012Amendment by applicant (claims and/or description)
20.08.2013Application deemed to be withdrawn, date of legal effect  [2014/07]
24.09.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/07]
Fees paidRenewal fee
25.09.2012Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.09.201304   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2007047207  (AMIRA PHARMACEUTICALS INC [US], et al) [A] 1-15* figures 12-13; claims 1,42,128,134 *;
 [A]US2007105866  (HUTCHINSON JOHN H [US], et al) [A] 1-15 * paragraph [0003] - paragraph [0006]; figures 8-11; claims 1,17-21 *
International search[A]JPH06184148  (ASAHI GLASS CO LTD, et al);
 [A]US5440046  (WAGNER ADALBERT [DE], et al);
 [A]WO2009027077  (UNIV JW GOETHE FRANKFURT MAIN [DE], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.